Dificlir Articles
IQWiG finds no added proven benefit for Astellas' fidaxomicin in Clostridium difficile infection
23 April 2013
UK's NICE launches new medicines advisory service
15 July 2012
Astellas and Optimer’s C. difficile drug cleared in Europe
13 December 2011
More news from EMA/CHMP September meeting
26 September 2011
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
